XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis
Authors
Keywords
XRCC1, XPD, Polymorphism, Gastric cancer, Meta-analysis
Journal
TUMOR BIOLOGY
Volume 35, Issue 6, Pages 5637-5645
Publisher
Springer Nature
Online
2014-03-04
DOI
10.1007/s13277-014-1746-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GSTP1, ERCC1 and ERCC2 Polymorphisms, Expression and Clinical Outcome of Oxaliplatin-based Adjuvant Chemotherapy in Colorectal Cancer in Chinese Population
- (2013) Hui-Yan Li et al. Asian Pacific Journal of Cancer Prevention
- Results of docetaxel plus oxaliplatin (DOCOX)±cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study
- (2013) Donald Richards et al. EUROPEAN JOURNAL OF CANCER
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin
- (2012) Robert F. Murphy et al. CELL CYCLE
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- Quantifying the impact of between-study heterogeneity in multivariate meta-analyses
- (2012) Dan Jackson et al. STATISTICS IN MEDICINE
- Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity
- (2011) Nora Graf et al. CHEMBIOCHEM
- ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis
- (2011) Ming Yin et al. CLINICAL CANCER RESEARCH
- Which One among the Pt-Containing Anticancer Drugs More Easily Forms Monoadducts with G and A DNA Bases? A Comparative Study among Oxaliplatin, Nedaplatin, and Carboplatin
- (2011) Marta E. Alberto et al. INORGANIC CHEMISTRY
- Pharmacogenetic Study in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy: Polymorphisms in Thymidylate Synthase, Epidermal Growth Factor Receptor, GSTP1, and DNA Repair Genes
- (2011) David Páez et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Protective autophagy antagonizes oxaliplatin-induced apoptosis in gastric cancer cells
- (2011) Ling Xu et al. Chinese Journal of Cancer
- Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population
- (2010) Tao Yuan et al. Cancer Epidemiology
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer
- (2009) Jun Liang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
- (2009) Zhao-Hui Huang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA Repair in Mammalian Cells
- (2009) T. Nouspikel CELLULAR AND MOLECULAR LIFE SCIENCES
- XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis
- (2009) Bin Wang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
- (2008) Bhumsuk Keam et al. BMC CANCER
- Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk
- (2008) Darren Tse et al. CANCER CAUSES & CONTROL
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis
- (2008) Brad J. Biggerstaff et al. STATISTICS IN MEDICINE
- ERCC1 polymorphism, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in gastric cancer
- (2008) Zhao-Hui Huang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More